Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Feb 02, 2023 5:34pm
180 Views
Post# 35263484

RE:25% percentage shareholding limitations

RE:25% percentage shareholding limitations
molotov420 wrote: I guess they still have some of the $280K left if they are delaying the vote. How much more than 25% do they want to issue next and why so much more than the first round? Currently to get to 25% we are talking another 28.8M which at today's price is worth $1.7M....more info needed. And is that Rory looking to convert more of his cash into shares lol....poor guy. 


All you can know for sure is that none of the people involved in this company give a rats a$$ about you or any of the other nobody shareholders.

Its clear they will do only what is good for themselves.  

Why was CARE oncology bought?  Cause Stage was able to trick those suckers into taking so many shares for their company.  Stage knew they would eventually become worthless so while they had a chance to buy a company that actually made some money they did it so they could keep their paychecks flowing.

Aristotle makes $0 and even CARE is starting to make less and less.

I gotta give them credit they scammed some smart people out of their company and money.
<< Previous
Bullboard Posts
Next >>